Clinical Trial Update: Study of Plitidepsin (Aplidin®) in Combination With Bortezomib and Dexamethasone in Patients With Multiple Myeloma [Phase 1]

View source ↗

Summary

Phase 1 trial investigating plitidepsin in combination with bortezomib and dexamethasone in patients with multiple myeloma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Aplidin (plitidepsin)
• Bortezomib (bortezomib)
• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: PharmaMar | Conditions: Multiple Myeloma | Phase 1 | Status: COMPLETED | Results posted: 2020-10-12